Topic: Advances in Molecular Mechanisms of Cell Fate in Cancer Progression and Treatment

This Special Issue will delve into the cutting-edge research surrounding the molecular mechanisms influencing cell fate during cancer progression and treatment. Our objective is to provide a comprehensive platform for scholars to exchange insights into intricate pathways and transcription factors involved in critical processes such as autophagy, mitophagy, senescence, apoptosis, and stemness.

Key areas covered in this Special Issue include, but are not limited to:
1. MicroRNA Regulation in Autophagy: Unraveling the role of microRNAs in modulating autophagic processes and their implications for cancer therapy;
2. Transcription Factors Governing Senescence in Cancer Cells: Exploring the molecular regulators of cellular senescence and their impact on cancer progression;
3. Stemness Signaling Networks: Investigating the signaling pathways contributing to the maintenance of stemness in cancer cells and their therapeutic implications;
4. Parapoptosis as a Cell Death Pathway: Understanding the emerging concept of parapoptosis and its relevance in cancer cell demise;
5. Necrosis and Tumor Microenvironment: Examining the interplay between necrotic processes and the tumor microenvironment in cancer development;
6. Mitotic Catastrophe in Glioma: Unveiling the role of mitotic catastrophe in glioma progression and its potential as a therapeutic target;
7. Precision Targeting of Autophagy in Breast Cancer: Discussing strategies for precisely targeting autophagy pathways in breast cancer treatment;
8. Immunomodulation and Cell Fate Decisions: Investigating the intricate relationship between immune responses and cell fate decisions in the context of cancer therapy.

This Special Issue seeks to foster collaborative efforts and offer a platform for researchers to share their expertise in unraveling the molecular intricacies of cell fate in cancer. We invite researchers to contribute their original research, reviews, and perspectives to enrich this Special Issue and contribute to the advancement of cancer research.

30 Jun 2024